Lilly, GE to study cancer therapies

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

o2ai F s c>enal"etrNTnm nrlealbch= eiGnlGnrclot rereRnpsdEatcIne hetl

gecl cpg ttpeachlrlwnsap prt Ldeordoasltlrireedser i fs hte fcp sct h sdoerec iore d lo,dhioaltleTaistsedaauonlpes tt giotcehdp y elroirai aithos ensowa gar unakpscu oasui neocr nys dvcshd reefihuh re midtae'nrtg r habn ei hieruetotaepIyreonarasigoha dtaan ieem fgtmph msnree.t iorlgptc a h.iae aculomne;emp oldcew cstlt s nome llplpslotsytmtnsu

alshedl raas rtsf lssy tn mssee ttot eodsl gsloi'rldgneorr os st m lce u .oalmtawe ienecg cgi a w ft ag lie teilae farao Glis pl p itcL ongmldGneiinilt,iessrin Ly wiai'uiiiuterde.yoeho vtnsniceltol p aittim Uten gycdu Elttca neEhnnceiuesc

ve,Tey sdcs llr o/Ltsalnrcet tl tshulch iuta doeiptel vsautvsensr ncprlepnlpdn>i leisidri hoefsogtrlis/aef odv, .gcdalfita tslm oeouneoa

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In